• LAST PRICE
    8.2800
  • TODAY'S CHANGE (%)
    Trending Down-0.7300 (-8.1021%)
  • Bid / Lots
    8.2700/ 9
  • Ask / Lots
    8.2900/ 7
  • Open / Previous Close
    8.3200 / 9.0100
  • Day Range
    Low 8.1000
    High 8.5500
  • 52 Week Range
    Low 3.5000
    High 9.9200
  • Volume
    5,070,032
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 9.01
TimeVolumeWVE
09:32 ET2605238.26
09:34 ET671398.4
09:36 ET2316808.45
09:38 ET1238378.52
09:39 ET785818.4696
09:41 ET564988.3656
09:43 ET417908.3999
09:45 ET1317238.395
09:48 ET635238.4105
09:50 ET541858.39
09:52 ET694648.25
09:54 ET1022208.31
09:56 ET220868.36
09:57 ET178608.41
09:59 ET636998.335
10:01 ET166088.37
10:03 ET309128.44
10:06 ET1548218.485
10:08 ET598428.4101
10:10 ET376608.5
10:12 ET194918.46
10:14 ET143398.44
10:15 ET253248.44
10:17 ET627668.43
10:19 ET113138.4055
10:21 ET109898.435
10:24 ET319298.41
10:26 ET192638.35
10:28 ET300418.41
10:30 ET244608.39
10:32 ET299608.45
10:33 ET142708.48
10:35 ET794228.495
10:37 ET99978.51
10:39 ET133358.5
10:42 ET131658.49
10:44 ET362068.53
10:46 ET999258.45
10:48 ET80328.45
10:50 ET307858.49
10:51 ET111988.49
10:53 ET100518.4476
10:55 ET191848.3401
10:57 ET315798.35
11:00 ET232008.27
11:02 ET142318.31
11:04 ET194728.32
11:06 ET147108.3
11:08 ET233228.3
11:09 ET125528.3806
11:11 ET164778.39
11:13 ET83188.43
11:15 ET112888.44
11:18 ET79938.45
11:20 ET96138.45
11:22 ET223268.48
11:24 ET192478.49
11:26 ET107438.48
11:27 ET152468.47
11:29 ET192368.47
11:31 ET692688.47
11:33 ET156368.49
11:36 ET113658.47
11:38 ET86098.4882
11:40 ET37808.48
11:42 ET129008.4479
11:44 ET86028.48
11:45 ET63908.49
11:47 ET82058.48
11:49 ET61528.47
11:51 ET73788.46
11:54 ET127828.465
11:56 ET74068.45
11:58 ET180238.42
12:00 ET22228.435
12:02 ET104588.4
12:03 ET125988.42
12:05 ET95368.34
12:07 ET124158.37
12:09 ET32648.375
12:12 ET72508.36
12:14 ET56208.405
12:16 ET84578.4
12:18 ET39788.4001
12:20 ET114768.38
12:21 ET66078.38
12:23 ET110908.35
12:25 ET15008.34
12:27 ET141318.325
12:30 ET33688.33
12:32 ET108158.32
12:34 ET12588.32
12:36 ET302148.36
12:38 ET50838.4
12:39 ET65388.39
12:41 ET45048.4
12:43 ET130518.38
12:45 ET28718.37
12:48 ET85008.355
12:50 ET74638.35
12:52 ET252028.32
12:54 ET155078.305
12:56 ET104978.34
12:57 ET75188.355
12:59 ET250078.4
01:01 ET69008.4
01:03 ET161278.4
01:06 ET30648.38
01:08 ET108968.38
01:10 ET71678.3976
01:12 ET32008.4
01:14 ET86118.37
01:15 ET51028.39
01:17 ET101108.385
01:19 ET37658.385
01:21 ET135898.33
01:24 ET209108.325
01:26 ET739638.24
01:28 ET250788.23
01:30 ET246778.22
01:32 ET114998.28
01:33 ET160558.32
01:35 ET214498.33
01:37 ET932748.21
01:39 ET672008.19
01:42 ET163728.195
01:44 ET194638.23
01:46 ET121808.22
01:48 ET137118.23
01:50 ET139238.26
01:51 ET41678.26
01:53 ET89748.23
01:55 ET195488.29
01:57 ET25008.29
02:00 ET150068.26
02:02 ET70998.28
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesWVE
WAVE Life Sciences Ltd
1.1B
-14.3x
---
United StatesGYRE
Gyre Therapeutics Inc
1.2B
-15.0x
---
United StatesPRTA
Prothena Corporation PLC
1.1B
-20.1x
---
United StatesTVTX
Travere Therapeutics Inc
1.1B
-3.1x
---
United StatesRCUS
Arcus Biosciences Inc
1.4B
-4.9x
---
United StatesVIR
Vir Biotechnology Inc
992.0M
-2.0x
---
As of 2024-09-26

Company Information

Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).

Contact Information

Headquarters
7 Straits View #12-00, Marina One East Tower, Singapore 018936
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Christian Henry
President, Chief Executive Officer, Director
Paul Bolno
Chief Financial Officer
Kyle Moran
Senior Vice President, Corporate Development & Portfolio Management
Christopher Francis
Chief Technology Officer, Head - Platform Discovery Sciences
Chandra Vargeese

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$110.5M
Shares Outstanding
124.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-1.13
EPS
$-0.58
Book Value
$0.40
P/E Ratio
-14.3x
Price/Sales (TTM)
10.2
Price/Cash Flow (TTM)
---
Operating Margin
-75.74%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.